| Opinion: Direct-to-consumer advertising of prescription medicines: a counter argument. | |
| | |
MedLine Citation:
|
PMID: 21425978 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Direct-to-consumer advertising of prescription-only medicines is currently only permitted in the USA and New Zealand. Barbara Mintzes and Dee Mangin provide their case against direct-to-consumer advertising of prescription medicines, arguing that its wider introduction would lead to a 'Pharma-knows-best' culture. |
| | |
Authors:
|
Barbara Mintzes; Dee Mangin |
Related Documents
:
|
22506158 - Defining physiatry and future scope of rehabilitation medicine. 23184158 - Controversies in obstetric anesthesia. 4927658 - The toxoplasma gondii oocyst from cat feces. 21986838 - Management of adult rhinosinusitis. 3898398 - Missionary doctors vs chinese patients: credibility of missionary health care in early ... 1290738 - The incompetent cervix--a review. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Future medicinal chemistry Volume: 1 ISSN: 1756-8927 ISO Abbreviation: Future Med Chem Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2011-03-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101511162 Medline TA: Future Med Chem Country: England |
Other Details:
|
Languages: eng Pagination: 1555-60 Citation Subset: IM |
Affiliation:
|
Therapeutics Initiative, University of British Columbia, 2176 Health Services Mall, Vancouver BC, V6T 1Z3, Canada. barbara.mintzes@ti.ubc.ca. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Studies on peptidyl nucleoside antibiotics: synthesis and antifungal evaluation of pyranosyl nucleos...
Next Document: Novel potent pharmacological cyclin-dependent kinase inhibitors.